Influenza Related Illness/Influenza Virus

The influenza vaccine is less effective in the elderly. It is unknown whether influenza vaccination of nonelderly adults confers additional disease protection on the elderly population.  In a large, nationwide sample of Medicare beneficiaries, influenza vaccination among adults aged 18–64 years was inversely associated with illnesses related to influenza in the elderly. This year, the global market for products used in the fight against influenza will be worth an estimated $5.5 billion, according to a new technical market research report, the Global Influenza Market, from BCC Research. Market revenue is forecast to increase at a five-year compound annual growth rate (CAGR) of 8% from 2013 to 2018, totaling nearly $6 billion in 2018.

    Related Conference of Influenza Related Illness/Influenza Virus

    August 21-23, 2017

    3rd Annual Congress on Infectious Diseases

    San Francisco, California, USA
    September 7-9, 2017

    6thEuro-Global Conference on Infectious Diseases

    Paris, France
    September 13-14, 2017

    6th Annual Bacteriology and Parasitology Meeting

    Singapore
    October 30-November 1, 2017

    3rd Annual Congress on Rare Diseases and Orphan Drugs


    (10 Plenary Forums - 1 Event)
    San Antonio, Texas, USA
    November 06-07, 2017

    3rd International Conference on Flu and Emerging Infectious Diseases

    Las Vegas, Nevada, USA
    March 1-2, 2018

    5th International congress on Infectious Diseases

    Berlin, Germany
    June 11-12, 2018

    4th World Congress on Rare Diseases and Orphan Drugs

    Dublin, Ireland
    31st August-1st September 2018

    International Conference on Emerging Infectious Diseases

    Zurich, Switzerland

    Influenza Related Illness/Influenza Virus Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in